We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

63 hedge funds and large institutions have $86.7M invested in Pernix Therapeutics Holdings, Inc. in 2014 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,741% more call options, than puts

Call options by funds: $497K | Put options by funds: $27K

333% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 6

279% more capital invested

Capital invested by funds: $22.9M → $86.7M (+$63.8M)

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

47% more funds holding

Funds holding: 4363 (+20)

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

Holders
63
Holders Change
+20
Holders Change %
+46.51%
% of All Funds
1.82%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
26
Increased
14
Reduced
10
Closed
6
Calls
$497K
Puts
$27K
Net Calls
+$470K
Net Calls Change
+$470K

PTX Hedge Fund Activity: Q1 2014 in Review

63 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q1 2014, worth a combined $86.7M — up 279% from $22.9M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PTX positions and 6 closed out — a net gain of 20 holders — while 14 added to existing stakes and 10 trimmed.

The largest buyer was Broadfin Capital, opening a new position worth an estimated $11.6M. The largest seller was F&C Asset Management, cutting an estimated $1.8M.

  • 63 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q1 2014, up from 43 in Q4 2013.
  • Funds reported $86.7M of Pernix Therapeutics Holdings, Inc. stock for Q1 2014, up 279% quarter-over-quarter.
  • 26 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q1 2014 and 6 closed out, a net change of +20 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q1 2014 was Broadfin Capital, an estimated $11.6M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q1 2014 was F&C Asset Management, an estimated $1.8M sold.

Based on aggregated 13F filings for Q1 2014.